CTMX Earnings

CTMX reported its earnings on 2026-05-07, showcasing a revenue of 10.26M against an estimate of 3.49M, resulting in a 193.93% surprise. The EPS was -0.1, surpassing the expected -0.14 by 28.57%. The stock experienced a -0.5% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following CTMX's earnings announcement on 2026-05-07, the stock price moved by -0.5% on the day of the release. Over the subsequent five days, it saw a 0% change. Historically, CTMX's stock price tends to shift by an average of -10.42% in the 10 days leading up to earnings and -8.87% in the 10 days following, providing insight into potential market.

For 2026/Q2, analysts estimate CTMX's annual revenue to reach 14.79M, while the EPS is projected at -0.06. These estimates reflect recent revisions, with revenue estimates unchanged by 0% and EPS estimates unchanged by 0% over the past three months, indicating analyst expectation in the company's performance.

The correlation between CTMX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock's fundamentals. Over the past three months, revenue estimates for FY2025 were unchanged by 0%, while EPS estimates moved unchanged by 0%. This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, CTMX's stock price typically moves by -10.42% in the 10 days before its earnings and -8.87% in the 10 days after. For the upcoming 2026/Q2 earnings, analysts expect an EPS of -0.06 and revenue of 14.79M.

The earnings call summary reveals mixed signals. The financial performance shows a significant decrease in revenue, but there's a substantial increase in cash reserves due to recent financing. Product development and market strategy show promise with Varseta-M's ongoing studies and future plans, but there's uncertainty in execution and FDA interactions. The Q&A section highlights management's lack of clarity on some issues, which could concern investors. The overall sentiment is neutral, as positive long-term prospects are balanced by short-term uncertainties and financial challenges.